Genomed Spólka Akcyjna (WSE:GEN)

Genomed Spólka Akcyjna Revenue

Genomed Spólka Akcyjna had revenue of 6.76M PLN in the quarter ending March 31, 2026, with 7.32% growth. This brings the company's revenue in the last twelve months to 29.58M, up 21.90% year-over-year. In the year 2025, Genomed Spólka Akcyjna had annual revenue of 29.12M with 26.58% growth.

• Revenue (ttm): 29.58M
• Revenue Growth: +21.90%
• P/S Ratio: 1.15
• Revenue / Employee: 528.27K
• Employees: 56
• Market Cap: 34.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	29.12M	6.11M	26.58%
Dec 31, 2024	23.01M	525.20K	2.34%
Dec 31, 2023	22.48M	2.02M	9.88%
Dec 31, 2022	20.46M	565.09K	2.84%
Dec 31, 2021	19.89M	1.14M	6.08%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error